Synthomer (LON:SYNT) H1 2024 results

Key financial results

• Revenue: GBP 1.05 billion (unchanged in H1 2023).

• Net loss: GBP 29.3 million (loss reduced by 40% from H1 2023).

• £0.18 loss per share (improvement from £2.08 loss in H1 2023).

All figures shown in the graph above refer to the last 12 months (TTM)

Synthomer Earnings Insights

Average sales growth of 6.2% per annum is expected for the next three years. In contrast, a decline of 5.8% is forecast for the chemical industry in Great Britain.

Performance of British chemical industry.

The company’s shares fell 2.3 percent compared to the previous week.

Risk analysis

You should always think about the risks. A typical example: We have 3 warning signs for Synthomer You should be aware of these, and two of them are potentially serious.

Do you have feedback on this article? Are you concerned about the content? Contact us directly from us. Alternatively, send an email to editorial-team (at) simplywallst.com.

This Simply Wall St article is of a general nature. We comment solely on the basis of historical data and analyst forecasts, using an unbiased methodology. Our articles do not constitute financial advice. It is not a recommendation to buy or sell any stock and does not take into account your objectives or financial situation. Our goal is to provide you with long-term analysis based on fundamental data. Note that our analysis may not take into account the latest price-sensitive company announcements or qualitative materials. Simply Wall St does not hold any of the stocks mentioned.